EUVIMEDEUVIMED entdecken
Crossref

Prognostic Value of the C-Reactive Protein-albumin-lymphocyte Index For Patients With Recurrent οr Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab

Fumihiko Sato, Takeharu Ono, Akira Hiraki, Tsunehiro Oka, Toshiyuki Mitsuhashi, Masayasu Naito, Mioko Fukahori, Shintaro Sueyoshi, Itaru Mizobe, Masahiro Seki, Kiminobu Sato, Toshihiko Kawaguchi und 4 weitere

Anticancer Research · 2025

DOI: 10.21873/anticanres.17757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Fumihiko Sato und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan; satou_fumihiko@med.kurume-u.ac.jp. Hauptthemen laut MEDLINE: Nivolumab, Squamous Cell Carcinoma of Head and Neck, C-Reactive Protein, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NivolumabSquamous Cell Carcinoma of Head and NeckC-Reactive ProteinNeoplasm Recurrence, LocalLymphocytesHead and Neck NeoplasmsAntineoplastic Agents, ImmunologicalHumansMaleFemaleMiddle AgedPrognosisAgedRetrospective StudiesAdultAged, 80 and overBiomarkers, TumorLymphocyte Count

Stichwörter der Autor:innen

C-reactive protein-albumin-lymphocyte indexCALLY indexNivolumabhead and neckneutrophil-to-lymphocyte ratiosquamous cell carcinoma

Substanzen

NivolumabC-Reactive ProteinAntineoplastic Agents, ImmunologicalBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan; satou_fumihiko@med.kurume-u.ac.jp.
  • Department of Otolaryngology-Head and Neck Surgery, Kurume University School of Medicine, Kurume, Japan.
  • Hospital Director, Naito Hospital, Kurume, Japan.
  • Department of Otolaryngology, Iizuka Hospital, Iizuka, Japan.
  • Department of Otolaryngology, St. Mary's Hospital, Kurume, Japan.
  • Department of Otolaryngology, Omuta City Hospital, Omuta, Japan.

Zitieren

APA

Sato, F., Ono, T., Hiraki, A., Oka, T., Mitsuhashi, T., Naito, M., Fukahori, M., Sueyoshi, S., Mizobe, I., Seki, M., Sato, K., Kawaguchi, T., Tanaka, H., Kurita, T., Chitose, S. I., & Umeno, H. (2025). Prognostic Value of the C-Reactive Protein-albumin-lymphocyte Index For Patients With Recurrent οr Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab. Anticancer Research. https://doi.org/10.21873/anticanres.17757

Vancouver

Sato F, Ono T, Hiraki A, Oka T, Mitsuhashi T, Naito M, et al. Prognostic Value of the C-Reactive Protein-albumin-lymphocyte Index For Patients With Recurrent οr Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab. Anticancer Research. 2025. doi:10.21873/anticanres.17757

BibTeX
@article{Sato2025,
  author = {Sato, Fumihiko and Ono, Takeharu and Hiraki, Akira and Oka, Tsunehiro and Mitsuhashi, Toshiyuki and Naito, Masayasu and Fukahori, Mioko and Sueyoshi, Shintaro and Mizobe, Itaru and Seki, Masahiro and Sato, Kiminobu and Kawaguchi, Toshihiko and Tanaka, Hisaichiro and Kurita, Takashi and Chitose, Shun-Ichi and Umeno, Hirohito},
  title = {Prognostic Value of the C-Reactive Protein-albumin-lymphocyte Index For Patients With Recurrent οr Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17757}
}
Kostenlos starten →